GMO Dialogues | Patient Reported Outcomes Measures with Krister Cromm

Including patient-reported outcomes (PROs), in clinical trials, opens new and meaningful pathways to understanding medical care from the patient’s point of view. By combining clinical and patient-reported end points, trials featuring PROs can identify opportunities to improve patient health status and define treatment goals.
Krister Cromm, Fresenius Medical Care’s expert director of patient experience for clinical research, is leading the company’s evolution from disease-centered to person-centered integrated trial design.